Shares of Amarin climbed higher on Tuesday ahead of an FDA meeting for the company’s only drug, a prescription fish-oil derived pill called Vascepa. The gains came on the likelihood that the U.S. Food and Drug Administration advisory committee would recommend that the regulator grant a broader indication for the company’s drug. Amarin is seeking … Continue reading “Amarin Shares Explode Ahead of FDA Decision”
